Please vote for CHOP scientists Ian Krantz and Nancy Spinner, who are in the running for the Time 100--Time Magazine’s annual list of influential people from around the world.
Almost exactly 10 years after the successful completion of the Human Genome Project, President Obama on Tuesday unveiled another large, government-backed research project: the Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) initiative. Calling the brain “an enormous mystery waiting to be unlocked,” President Obama laid out broad plans for the project, which will devote more than $100 million to brain-mapping research in 2014, and has the potential “improve the lives of not just millions, but billions of people.”
The Children’s Hospital of Philadelphia and Pfizer, Inc., the world’s largest research-based pharmaceutical company, are joining forces with the goal of translating biomedical discoveries into novel treatments. Children’s Hospital is set join the Centers for Therapeutic Innovation (CTI) network, a novel collaboration model built by Pfizer that brings academic researchers together with Pfizer scientists to expedite the pace of innovation.
Tom Curran, PhD, FRS, Deputy Scientific Director of The Children’s Hospital of Philadelphia Research Institute, will be formally inducted into the AACR Academy on April 5 in Washington, D.C.
In February the blog Vaccine Nation named Dr. Offit one of the 50 most influential people in vaccines, and just recently he was awarded the 2013 Maxwell Finland Award for Scientific Achievement, given annually by the National Foundation for Infectious Diseases (NFID).
According to new research from The Children’s Hospital of Philadelphia and the University of Pennsylvania, two children with an aggressive form of childhood leukemia achieved a complete response after being treated with an innovative cell therapy.
A team of clinician-researchers from The Children’s Hospital of Philadelphia has created and validated the first set of standardized vital sign curves for heart rates and respiratory rates in hospitalized children.
Children who are later diagnosed with an autism spectrum disorder have subtle but measurable differences in attention as early as 7 months of age, a new study shows. Infants who went on to be diagnosed with autism are slower to shift their gaze from one object to another, according to the researchers, who identified specific brain circuits that seem to cause the slower response.
CHOP’s Peter Adamson, MD, who heads the Children’s Oncology Group, the largest organization in the world dedicated to childhood and adolescent cancer research, was recently interviewed by journalist Paul Goldberg for the March 15 issue of The Cancer Letter.
New on the Center for Injury Research and Prevention’s (CIRP) blog Research in Action are two stories that touch on a tragic topic: children and teenagers being injured in car crashes.